Innovation on a Mission
Visionary startups. Experienced VCs. Dedicated government professionals. In-Q-Tel leads from the center of this matrix, connecting cutting-edge technology, strategic investments, and purpose: to enhance and advance national security for the U.S. and its allies.
World-class, cutting-edge technologies for National Security
In-Q-Tel scouts the global market for cutting-edge technologies that have both high national security impact and the potential for commercial success. Investment areas include:
Digital Intelligence
Trusted Infrastructure
Autonomous Systems
Industry 4.0
Intelligent Connectivity
Data Analytics
AI and Machine Learning
IT Platforms
Blog & Resources
The Holodeck & The Future of History
Star Trek’s holodeck has long inspired dreams of digitizing our world into interactive, immersive, playable 3D space. Spatial computing is […]
The Teachable Camera Hardware
From Redux to Apollo Cache: What to Consider When Making the Switch
Take the Pain out of Orchestrating & Instrumenting Testbed Environments with Portunus
SpaceNet 7 Results: ‘Tis the Season
Subscribe
Getting Back to Work and School: Enhancing Access to COVID-19 Testing
In the era of COVID-19, how do we create safe environments for people to return to work, school, and their daily lives? B.Next’s Dr. Kevin O’Connell is joined by Troy Moore, Chief Scientific Officer and Founder at Kailos Genetics, an In-Q-Tel portfolio company providing cost-effective solutions that make genetic screening accessible to everyone. Listen in as the two explore the importance and impact of testing, genetic sequencing, the company’s capture and enrichment methodology adapted to work with the COVID-19 virus, and more.
Synthetic Biology: A Core Capability for Biosecurity
B.Next’s Dr. Kevin O’Connell is joined by Jason Kelly, Founder of Ginkgo Bioworks, an In-Q-Tel portfolio company using the most advanced technology on the planet—biology—to grow better products. Learn more about their platform that programs cells, and how they leverage this capability to expand biosecurity and pandemic response.
Learn more at ginkgobioworks.com.